Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

CSE/NARA stock hub

CSE/NARA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/NARAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.4M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/NARA

In the news

Latest news · CSE/NARA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/NARA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

136

Groups with data

Currency

CAD

Showing 136 of 136 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees Change	0%
Employees Change Percent	0
Enterprise value	CAD 13.5M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Health Information Services
Isin	CA69842E4031
Last refreshed	2026-05-10
Market cap	CAD 13.4M
Price	CAD 0.52
Price currency	CAD
Sector	Healthcare
Sic	7372
Symbol	cse/NARA
Website	https://pangenomic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-25.68%
EV Earnings	-3.95x
P/B ratio	-6.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	CAD -384,750
Net Income	CAD -3.4M
Net Income Growth Years	0%
ROA	-1,979
Roa5y	-802.4
ROCE	144.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	116.78%
Cagr3y	-44.24%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 160,910
Cash	CAD 38,766
Current Assets	CAD 159,548
Current Liabilities	CAD 2.3M
Debt	CAD 212,874
Equity	CAD -2.2M
Interest Coverage	-773.7
Liabilities	CAD 2.3M
Long Term Assets	CAD 1,362
Long Term Liabilities	CAD 0
Net Cash	CAD -174,108
Net Cash By Market Cap	CAD -1.3
Tangible Book Value	CAD -2.2M
Tangible Book Value Per Share	CAD -0.08
WACC	0.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.07
Net Working Capital	CAD -2M
Quick ratio	0.02
Working Capital	CAD -2.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-295.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	116.67%
200-day SMA	1.05
3Y total return	-82.67%
50-day SMA	0.52
50-day SMA vs 200-day SMA	50under200
All Time High	18.25
All Time High Change	-97.15%
All Time High Date	2023-01-17
All Time Low	0.07
All Time Low Change	642.86%
All Time Low Date	2024-11-28
ATR	0.07
Beta	-0.76
Beta1y	-0.91
Beta2y	0.64
Ch YTD	14.29
High	0.62
High52	2.57
High52 Date	2025-09-23
High52ch	-79.77%
Low	0.48
Low52	0.16
Low52 Date	2025-05-12
Low52ch	225%
Ma50ch	-0.86%
Price vs 200-day SMA	-50.52%
RSI	52.87
RSI Monthly	36.25
RSI Weekly	38.59
Sharpe ratio	1.65x
Sortino ratio	2.92
Total Return	-295.51%
Tr YTD	14.29
Tr1m	9.47%
Tr1w	15.56%
Tr3m	4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -3.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,545,026%
Net Borrowing	168,874
Shares Insiders	0.57%
Shares Out	25,700,276
Shares Qo Q	65.74%
Shares Yo Y	295.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	4,339.05x
Bv Per Share	-0.08
Ch1m	9.47
Ch1w	15.56
Ch1y	116.7
Ch3m	4
Ch3y	-82.67
Ch6m	-48
Change	15.56%
Change From Open	4
Close	0.45
Days Gap	11.11
Depreciation Amortization	628
Dollar Volume	6,547.8
Earnings Date	2026-05-15
EBIT	CAD -3.2M
EBITDA	CAD -3.2M
EPS	CAD -0.19
F Score	1
Financing CF	1,919,071
Fiscal Year End	December
Founded	2,015
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2025-12-31
Last Split Date	2024-11-14
Last Split Type	Reverse
Ma150	1.27
Ma150ch	-58.93%
Ma20	0.43
Ma20ch	20.18%
Net CF	37,459
Next Earnings Date	2026-05-15
Open	0.5
Position In Range	28.57
Ppne	1,362
Price Date	2026-05-08
Relative Volume	3.3x
Share Based Comp	1,198,096
Tr6m	-48%
Volume	12,592

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/NARA pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/NARA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/NARA?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+295.5%

Negative means the company is buying back shares.

Technical

CSE/NARA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.9

Neutral momentum band

Price vs 200-day MA

-50.5%

50/200-day relationship not available

Beta (5Y)

-0.76

Less volatile than the market

Sharpe ratio

1.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/NARA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/NARA stock rating?

cse/NARA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/NARA analysis?

The full report lives at /stocks/cse/NARA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/NARA?

The latest report frames cse/NARA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/NARA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.